 |
|
 |
Faculty
|
|
David H. Sherman
Hans W. Vahlteich Professor of Medicinal Chemistry
Research Professor, Life Sciences Institute
Professor of Chemistry and Microbiology & Immunology
Ph.D., Columbia University
Postdoctoral Fellow, Yale University and MIT
Research Focus: Bioorganic Chemistry, Molecular Genetics and Biochemistry
Phone: 734.615.9907
Email: davidhs@umich.edu
Fax: 734.615.3641
|
The Sherman laboratory works at the interface of bioorganic chemistry
and molecular microbiology through the investigation of secondary
metabolic systems involved in natural product biosynthesis. Several
projects are being pursued in the group including genomic analysis
of antibiotic biosynthesis in Streptomyces spp., investigation of
the molecular genetics and biochemistry of cyanobacterial secondary
metabolic systems, synthetic chemistry of complex natural product
substrates to investigate the specificity and mechanisms of natural
product biosynthetic enzymes, and development of culture methods
for isolation of novel marine bacteria rich in of bioactive metabolite
production.
We are using microarray analysis of the Streptomyces coelicolor
genome to investigate the network of regulators involved in production
of secondary metabolites. This project involves engineering of select
mutations into the genome focused on two-component regulatory systems
and analysis their phenotypic impact relating to production of actinorhodin,
undecylprodigiosin and calcium dependent antibiotic. The ultimate
goal is to understand the web of signals involve in physiological
development (e.g. bioactive metabolite production) in Streptomyces.
A growing effort is underway to investigate a series of fascinating
cyanobacterial derived metabolic pathways including the anticancer
compounds cryptophycin and curacin. In this program, we are combining
the isolation and analysis of specific metabolic pathway genes and
enzymes coupled with synthetic chemistry to analyze the specificity
and mechanism of chain elongation, processing and cyclization leading
to new bioactive molecules. This program is providing novel tools
for chemoenzymatic construction of complex molecules that are difficult
to access using synthetic methods alone.
Within the past several years we have developed a program to isolate
and investigate new types of marine bacteria from biodiverse tropical
reef habitats. This project has already resulted in thousands of
new bacterial isolates within the actinomycetes group of gram positive
bacteria known to produce diverse natural product structures. Extracts
from these cultures are being analyzed in our laboratory and those
of our collaborators (including two pharmaceutical companies) to
discover novel anti-cancer and anti-infective agents. As new high
interest compounds are defined, we embark on molecular genetic characterization
of the biosynthetic gene cluster and pursue biochemical studies
on enzymes involved in natural product structural assembly, cellular
resistance or transport mechanisms.
Awards
Hans W. Vahlteich Professorship, 2007-present
John Gideon Searle Professorship, 2003-2006
Procter & Gamble University Exploratory Research Program, 1992-1995
Eli Lilly Life Sciences Award, 1990-1992
Myron A. Bantrell Postdoctoral Research Fellowship in Molecular
Biology, 1984-1986
National Institutes of Health Postdoctoral Fellowship, 1982-1984
Pegram Award for Excellence in Graduate Research, Columbia University,
1981
American Chemical Society Award for Excellence in Undergraduate
Research, 1978
University of California, Santa Cruz, Honors in the Major (Chemistry),
1978
Representative Publications
1. Lian, W., Jayapal, K.P., Charaniya, S., Mehra, S., Glod, F., Kyung, Y.S., Sherman, D.H., Hu, W.S., "Genome-wide transcriptome analysis reveals that a pleiotropic antibiotic regulator, AfsS, modulates nutritinoal stress resonse in Streptomyces coelicolor A3(2)", BMC Genomics, 2008, 9, 56.
2. Ding, Y., Seufert, W., Beck, Z.Q., Sherman, D.H., "Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperataivity", J. Am. Chem. Soc. (ASAP).
3. Miller, K.A., Welch, T.R., Greshock, T.J., Ding, Y., Sherman, D.H., Williams, R.M., "Biomimetic total synthesis of malbrancheamide and malbranceamide", B. J. Org. Chem. (ASAP).
4. Buchholz, T.J., Kittendorf, J.D. and Sherman, D.H., "Polyketide biosynthesis, modular polyketide synthases", Wiley Encyclopedia of Chem. Biol., 2007, (in press).
5. Gu, L.C., Geders, T.W., Wang, B., Gerwick, W.H., Hakansson, K., Smith, J.L. and Sherman, D.H., "GNAT-like strategy for polyketide chain initiation", Science, 2007, 318, 970.
6. Geders, T.W., Gu, L.C., Mowers, J.C., Liu, H., Gerwick, W.H.,
Hakansson, K., Sherman, D.H. and Smith, J.L., "Crystal structure
of the ECH2 catalytic domain of CurF from Lyngbya
Majuscula: Insights into a decarbozylase involved in polyketide
chain β-branching", J. Biol. Chem., 2007, 282, 35954,
(online).
7. Li, S., Podust, L.M. and Sherman, D.H., "Engineeering and analysis of a self-sufficient biosynthetic cytochrome P450 PikC fused to the RhFRED reductase domain", J. ACS., 2007, 129, 12940.
|
 |
 |